C. McGuirt

Improvements in clinical benefit with vinorelbine in the treatment of hormone-refractory prostate cancer: a phase II trial.

G. Wilding, H. Burris, M. O'Rourke, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Multicenter phase II study to evaluate a 28-day regimen of oral fluorouracil plus eniluracil in the treatment of patients with previously untreated metastatic colorectal cancer.

R. Schilsky, S. Mani, M. O'Rourke, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Vinorelbine as first-line chemotherapy for advanced breast cancer in women 60 years of age or older.

C. Vogel, M. O'Rourke, H. Hochster, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Dose-intensive vinorelbine with concurrent granulocyte colony-stimulating factor support in paclitaxel-refractory metastatic breast cancer.

R. Livingston, M. Williams, G. Ellis, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Multicenter phase II study of a 28-day regimen of orally administered eniluracil and fluorouracil in the treatment of patients with anthracycline- and taxane-resistant advanced breast cancer.

G. Hortobagyi, L. Sutton, M. Somerville, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Oral eniluracil/5-fluorouracil in patients with inoperable hepatocellular carcinoma.

A. Benson, E. Mitchell, P. Ritch, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.